Scientists probe why vaccines work differently in men, women, and transgender people
NCT ID NCT06832514
Summary
This study aims to understand how biological sex and gender identity affect the body's immune response to a vaccine. Researchers will give a licensed meningitis B vaccine to 250 healthy transgender and cisgender adults and measure their antibody and T-cell levels. The goal is to learn if hormone therapy or other factors lead to different levels of protection from the vaccine.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VACCINATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CEVAC, University Hospital Ghent, Belgium
RECRUITINGGhent, 9000, Belgium
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.